Orchid Pharma has an EPS of $11.35. In 2022, the company made an earnings per share (EPS) of $-0.48. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | $11.35 | -2464.58% |
2022 | -$0.48 | -98.32% |
2021 | -$28.55 | 93.56% |
2020 | -$14.75 | - |